




Searching News Database: Nabi Biopharmaceuticals
HSMN NewsFeed - 29 Jul 2019
RenalytixAI Appoints Thomas McLain as President and Chief Commercial Officer
RenalytixAI Appoints Thomas McLain as President and Chief Commercial Officer
HSMN NewsFeed - 5 Jan 2015
Catalyst Pharmaceuticals Appoints David D. Muth, Executive Vice President, Chief Commercial Officer
Catalyst Pharmaceuticals Appoints David D. Muth, Executive Vice President, Chief Commercial Officer
HSMN NewsFeed - 13 Mar 2013
Vermillion Appoints Thomas McLain as President and Chief Executive Officer
Vermillion Appoints Thomas McLain as President and Chief Executive Officer
HSMN NewsFeed - 7 Nov 2011
Nabi Biopharmaceuticals Announces Results of Second NicVAX(R) Phase III Clinical Trial
Nabi Biopharmaceuticals Announces Results of Second NicVAX(R) Phase III Clinical Trial
HSMN NewsFeed - 16 Nov 2009
GSK and Nabi Announce Agreement for NicVAX(R), a Vaccine for Nicotine Addiction
GSK and Nabi Announce Agreement for NicVAX(R), a Vaccine for Nicotine Addiction
HSMN NewsFeed - 22 Jan 2008
Nabi Biopharmaceuticals Names Dr. Raafat E.F. Fahim as President and Chief Executive Officer
Nabi Biopharmaceuticals Names Dr. Raafat E.F. Fahim as President and Chief Executive Officer
HSMN NewsFeed - 4 Dec 2007
Biotest Pharmaceuticals Corporation Completes Acquisition of Nabi Biologics Business Unit
Biotest Pharmaceuticals Corporation Completes Acquisition of Nabi Biologics Business Unit
HSMN NewsFeed - 2 May 2007
Nabi Biopharmaceuticals Announces Positive Results of Phase IIb Trial of NicVAX
Nabi Biopharmaceuticals Announces Positive Results of Phase IIb Trial of NicVAX
HSMN NewsFeed - 16 Jan 2007
Nabi Biopharmaceuticals Announces Initiation of Civacir(R) Phase II 'Proof-of- Concept' Clinical Trial
Nabi Biopharmaceuticals Announces Initiation of Civacir(R) Phase II 'Proof-of- Concept' Clinical Trial
HSMN NewsFeed - 14 Nov 2006
Nabi Biopharmaceuticals Closes Sale of PhosLo(R) to Fresenius Medical Care
Nabi Biopharmaceuticals Closes Sale of PhosLo(R) to Fresenius Medical Care
HSMN NewsFeed - 16 Oct 2006
Nabi Biopharmaceuticals Announces Positive Results From PhosLo(R) EPICK Study
Nabi Biopharmaceuticals Announces Positive Results From PhosLo(R) EPICK Study
HSMN NewsFeed - 12 Oct 2006
Nabi Biopharmaceuticals Signs Definitive Agreement To Sell PhosLo(R) To Fresenius Medical Care
Nabi Biopharmaceuticals Signs Definitive Agreement To Sell PhosLo(R) To Fresenius Medical Care
HSMN NewsFeed - 12 Oct 2006
Fresenius Medical Care to Acquire Phosphate Binder Business from Nabi Biopharmaceuticals
Fresenius Medical Care to Acquire Phosphate Binder Business from Nabi Biopharmaceuticals
HSMN NewsFeed - 26 Sep 2006
Third Point LLC Announces Consent Solicitation to Remove Nabi Biopharmaceuticals Board Chairman
Third Point LLC Announces Consent Solicitation to Remove Nabi Biopharmaceuticals Board Chairman
HSMN NewsFeed - 29 Jun 2006
Nabi Biopharmaceuticals Secures Agreement with Kedrion to Co-Develop and Commercialize Civacir(R) in Europe
Nabi Biopharmaceuticals Secures Agreement with Kedrion to Co-Develop and Commercialize Civacir(R) in Europe
HSMN NewsFeed - 9 Mar 2006
Nabi Biopharmaceuticals Announces U.S. Fast Track Designation for NicVAX(R)
Nabi Biopharmaceuticals Announces U.S. Fast Track Designation for NicVAX(R)
HSMN NewsFeed - 30 Jan 2006
Nabi Biopharmaceuticals' Mark L. Smith Resigns as Company's CFO, Effective on or Around March 1, 2006
Nabi Biopharmaceuticals' Mark L. Smith Resigns as Company's CFO, Effective on or Around March 1, 2006
HSMN NewsFeed - 25 Jan 2006
Nabi Biopharmaceuticals Provides Update on Strategic Direction of NicVAX(TM) Program
Nabi Biopharmaceuticals Provides Update on Strategic Direction of NicVAX(TM) Program
Additional items found! 38

Members Archive contains
38 additional stories matching:
Nabi Biopharmaceuticals
(Password required)
Nabi Biopharmaceuticals
(Password required)